166
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Design and synthesis of a sulphur containing Schiff base drug: DNA binding studies and theoretical calculations

, , , , , & show all
Pages 263-271 | Received 04 Oct 2019, Accepted 18 Dec 2019, Published online: 08 Jan 2020
 

Abstract

The Schiff base compound MTA ((E)-5-methyl-N'-((5-methylthiophen-2-yl)methylene)-1H-pyrazole-3-carbohydrazide) derived from 2-thiophenecarboxaldehyde and 5-methylpyrazole-3-carbohydrazide has been designed to develop new sulphur containing DNA targeted molecule. The MTA has been characterized by elemental analyses, 1H-NMR, single crystal X-ray diffraction studies as well as by geometry optimization of using DFT/B3LYP. The interaction of MTA with Calf thymus DNA (CT-DNA) was studied by spectroscopic and calorimetric techniques. The synthesized compound was found to bind with CT-DNA through groove binding mode, and the binding constant was estimated to be (4.15 ± 0.08) × 104 M−1. The negative ΔG0 and positive ΔS0 values obtained from the calorimetric technique confirmed the spontaneity of the binding of MTA with DNA.

Communicated by Ramaswamy H. Sarma

Acknowledgements

US and MD thank Science & Engineering Research Board (SERB), Govt. of India for the award of National Post-doctoral fellowships (Ref. No.PDF/2016/000080 and Ref No.PDF/2016/000334). SK thanks The Bhawanipur Education Society College for providing the research grant.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.